Thyrocare secures NABL accreditation for its Labs
Thyrocare becomes first national diagnostic chain with 100% of its labs with NABL accreditation
Thyrocare becomes first national diagnostic chain with 100% of its labs with NABL accreditation
Exploring new opportunities within the fast-growing market of microfluidics
Till 30th November 2024, more than 2690 PACS have been given initial approval and 687 Kendras have been opened in PACS
Recommendation based on LAURA Phase III trial results which showed Tagrisso extended median progression-free survival to more than three years
Opinion granted based on positive overall survival results from the IND.227/KEYNOTE-483 trial
The FDA conducted a comprehensive Pre-Approval Inspection (PAI) and cGMP audit
The GMP certificate will allow the manufacturing site in Hervás, Cáceres to manufacture active ingredients for the pharmaceutical industry that is based on medicinal plants
The authorization of bortezomib will enhance the company’s ability to deliver advanced cancer solutions in Southeast Asia
The Notes shall not be offered or sold in India
Subscribe To Our Newsletter & Stay Updated